Tectonic Therapeutic, Inc. — Investor Relations & Filings

Tectonic Therapeutic, Inc. is a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-Protein Coupled Receptors (GPCRs). The company utilizes its proprietary GEODe™ technology platform to design and create biologic medicines targeting this complex class of receptors. Tectonic's approach aims to address significant unmet medical needs in diseases where therapeutic options are limited or nonexistent. Its pipeline includes differentiated GPCR-targeted biologics for conditions such as Group 2 Pulmonary Hypertension and Hereditary Hemorrhagic Telangiectasia (HHT).